相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatitis C Virus Induces CD81 and Claudin-1 Endocytosis
Michelle J. Farquhar et al.
JOURNAL OF VIROLOGY (2012)
Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
Bruno Sainz et al.
NATURE MEDICINE (2012)
Second-Phase Hepatitis C Virus RNA Decline During Telaprevir-Based Therapy Increases With Drug Effectiveness: Implications for Treatment Duration
Jeremie Guedj et al.
HEPATOLOGY (2011)
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies
Mirjam B. Zeisel et al.
JOURNAL OF HEPATOLOGY (2011)
Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission
Claire L. Brimacombe et al.
JOURNAL OF VIROLOGY (2011)
Hepatitis C Virus Infection Causes Cell Cycle Arrest at the Level of Initiation of Mitosis
Rathi P. Kannan et al.
JOURNAL OF VIROLOGY (2011)
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
Joachim Lupberger et al.
NATURE MEDICINE (2011)
Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy
Ching-Sheng Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mathematical Model of Viral Kinetics In Vitro Estimates the Number of E2-CD81 Complexes Necessary for Hepatitis C Virus Entry
Pranesh Padmanabhan et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Ribavirin-Induced Anemia in Hepatitis C Virus Patients Undergoing Combination Therapy
Sheeja M. Krishnan et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes
Isabel Fofana et al.
GASTROENTEROLOGY (2010)
Inhibition of Hepatitis C Virus Infection by Anti-Claudin-1 Antibodies Is Mediated by Neutralization of E2-CD81-Claudin-1 Associations
Sophie E. Krieger et al.
HEPATOLOGY (2010)
Claudin Association with CD81 Defines Hepatitis C Virus Entry
Helen J. Harris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Evaluating treatment of hepatitis C for hemolytic anemia management
Swati DebRoy et al.
MATHEMATICAL BIOSCIENCES (2010)
Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
Libin Rong et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
The rate of hepatitis C virus infection initiation in vitro is directly related to particle density
Ali Sabahi et al.
VIROLOGY (2010)
A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants
Bambang S. Adiwijaya et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Treatment of Hepatitis C Virus Infection With Interferon and Small Molecule Direct Antivirals: Viral Kinetics and Modeling
Libin Rong et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2010)
Development of a Cell-Based Hepatitis C Virus Infection Fluorescent Resonance Energy Transfer Assay for High-Throughput Antiviral Compound Screening
Xuemei Yu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection
Shufeng Liu et al.
JOURNAL OF VIROLOGY (2009)
Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon
Harel Dahari et al.
JOURNAL OF VIROLOGY (2009)
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Alexander Ploss et al.
NATURE (2009)
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes
Kathie-Anne Walters et al.
PLOS PATHOGENS (2009)
Early and accurate prediction of Peg-IFNs/ribavirin therapy outcome in the individual patient with chronic hepatitis C by modeling the dynamics of the infected cells
P. Colombatto et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Modeling amantadine treatment of influenza A virus in vitro
Catherine A. A. Beauchemin et al.
JOURNAL OF THEORETICAL BIOLOGY (2008)
CD81 and claudin 1 coreceptor association: Role in hepatitis C virus entry
Helen J. Harris et al.
JOURNAL OF VIROLOGY (2008)
Hepatitis C virus receptor expression in normal and diseased liver tissue
Gary M. Reynolds et al.
HEPATOLOGY (2008)
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies
Jennifer M. Timpe et al.
HEPATOLOGY (2008)
Triphasic decline of hepatitis C virus RNA during antiviral therapy
Harel Dahari et al.
HEPATOLOGY (2007)
Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes
Torsten Schaller et al.
JOURNAL OF VIROLOGY (2007)
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Matthew J. Evans et al.
NATURE (2007)
Superinfection exclusion in cells infected with hepatitis C virus
Donna M. Tscherne et al.
JOURNAL OF VIROLOGY (2007)
Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells
Harel Dahari et al.
JOURNAL OF VIROLOGY (2007)
Persistent hepatitis C virus infection in vitro: Coevolution of virus and host
Jin Zhong et al.
JOURNAL OF VIROLOGY (2006)
Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells
Bruno Sainz et al.
JOURNAL OF VIROLOGY (2006)
Modelling how ribavirin improves interferon response rates in hepatitis C virus infection
NM Dixit et al.
NATURE (2004)
CD81 is an entry coreceptor for hepatitis C virus
EG Cormier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon
E Herrmann et al.
HEPATOLOGY (2003)
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
E Scarselli et al.
EMBO JOURNAL (2002)
Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a
S Zeuzem et al.
GASTROENTEROLOGY (2001)
分享论文
